Search results
Results from the WOW.Com Content Network
J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. [1] [2] [3] [4]The approach that lead to development of the J147 drug was to screen candidate molecules for anti-aging effects, instead of targeting the amyloid plaques.
Cerebrolysin (developmental code name FPF-1070) is an experimental mixture of enzymatically-treated peptides derived from pig brain whose constituents can include brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF).
Peptide therapeutics are peptides or polypeptides (oligomers or short polymers of amino acids) which are used to for the treatment of diseases. Naturally occurring peptides may serve as hormones , growth factors , neurotransmitters , ion channel ligands , and anti-infectives ; peptide therapeutics mimic such functions.
[2] [3] Chemically, Semax is a peptide and a synthetic analogue of a fragment of adrenocorticotropic hormone (ACTH). [4] [5] Semax was first described by 1991. [5] Although used as a prescription drug in Russia and Eastern Europe, Semax has not been evaluated, approved for use, or marketed in most other countries.
For premium support please call: 800-290-4726 more ways to reach us
Pacific Gateway was designated an Immigrant Resource Center in March by the Office of Community Serv ices overseeing the initiative, which serves primarily Maui but also Oahu, Kauai, Molokai and ...
[31] [33] [34] Per capita, West Virginia has the highest number of opioid-addicted individuals. [35] On November 1, 2019, the institute's Executive Chair Dr. Ali Rezai surgically implanted a deep brain stimulator chip into the nucleus accumbens part of the human brain to reduce human cravings for drugs, particularly opioids. [36]
Neptune Wellness Solutions, Inc. is a wellness company Quebec, Canada. Originally known for Antarctic krill oil production, the company previously operated an industrial-scale licensed cannabis processing plant in Quebec , CA, [ 1 ] and a hemp processing facility in North Carolina in the U.S. until selling the cannabis business in 2022.